SRAX (SRAX)
(Delayed Data from OTC)
$0.15 USD
0.00 (0.00%)
Updated Sep 25, 2024 10:57 AM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for SRAX, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | NA | 28 | 27 | 9 | 4 |
Cost Of Goods | NA | 9 | 7 | 3 | 2 |
Gross Profit | NA | 18 | 20 | 6 | 2 |
Selling & Adminstrative & Depr. & Amort Expenses | 0 | 14 | 20 | 18 | 20 |
Income After Depreciation & Amortization | 0 | 4 | 0 | -12 | -18 |
Non-Operating Income | NA | -31 | -6 | 9 | 2 |
Interest Expense | NA | 4 | 10 | 12 | 1 |
Pretax Income | NA | -32 | -16 | -15 | -17 |
Income Taxes | NA | NA | 0 | 0 | 0 |
Minority Interest | NA | NA | -6 | 0 | 0 |
Investment Gains/Losses | NA | NA | 0 | 0 | 0 |
Other Income/Charges | NA | NA | 0 | 0 | 0 |
Income From Cont. Operations | NA | -32 | -16 | -15 | -17 |
Extras & Discontinued Operations | NA | NA | -25 | 0 | 0 |
Net Income (GAAP) | NA | -32 | -35 | -15 | -17 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 0 | 15 | 2 | -1 | -17 |
Depreciation & Amortization (Cash Flow) | NA | 11 | 2 | 10 | 1 |
Income After Depreciation & Amortization | 0 | 4 | 0 | -12 | -18 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | NA | NA | 23.55 | 14.65 | NA |
Diluted EPS Before Non-Recurring Items | -99,999.00 | -99,999.00 | -0.68 | -0.84 | NA |
Diluted Net EPS (GAAP) | -99,999.00 | -1.21 | -1.48 | -1.00 | -1.36 |
Fiscal Year end for SRAX, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | NA | NA | 5.31 | 7.72 |
Cost Of Goods | NA | NA | NA | NA | NA |
Gross Profit | NA | NA | NA | NA | NA |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non-Operating Income | NA | NA | NA | NA | NA |
Interest Expense | NA | NA | NA | NA | NA |
Pretax Income | NA | NA | NA | NA | NA |
Income Taxes | NA | NA | NA | NA | NA |
Minority Interest | NA | NA | NA | NA | NA |
Investment Gains/Losses | NA | NA | NA | NA | NA |
Other Income/Charges | NA | NA | NA | NA | NA |
Income From Cont. Operations | NA | NA | NA | -3.82 | -23.03 |
Extras & Discontinued Operations | NA | NA | NA | 0.00 | 0.00 |
Net Income (GAAP) | NA | NA | NA | -3.82 | -23.03 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | NA | NA | 26.34 | 26.25 |
Diluted EPS Before Non-Recurring Items | -99,999.00 | -99,999.00 | NA | -0.14 | -0.88 |
Diluted Net EPS (GAAP) | -99,999.00 | -99,999.00 | NA | -0.14 | -0.88 |